CIBC Bancorp USA
BBH icon

CIBC Bancorp USA’s VanEck Biotech ETF BBH Stock Holding History

CIBC Bancorp USA’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.21M Hold
4,958
– – ﹤0.01% 1067
2026
Q2 		$1.01M Hold
4,958
– – ﹤0.01% 1103
2026
Q1 		$932K Buy
+4,958
New +$955K ﹤0.01% 1057

Other funds holding BBH

Raymond James Financial
Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Miller Investment Management
Miller Investment Management West Conshohocken, Pennsylvania $1.13B AUM 13.3% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Conservest Capital Advisors
Conservest Capital Advisors Wynnewood, Pennsylvania $1.28B AUM 17.34% 1-Year Est. Return
Paragon Private Wealth Management
Paragon Private Wealth Management Lexington, Kentucky $326M AUM 26.55% 1-Year Est. Return
Bleakley Financial Group
Bleakley Financial Group Fairfield, New Jersey $8.8B AUM 22.37% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $68.5B AUM 24.33% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $121B AUM 21.47% 1-Year Est. Return

CIBC Bancorp USA's BBH Position: Q3 2026 in Review

CIBC Bancorp USA held its VanEck Biotech ETF (BBH) position steady in Q3 2026 at 4,958 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1067.

CIBC Bancorp USA first reported a position in BBH in Q1 2026 and has held it in 3 quarters since. 103 funds tracked by Wall St. Rank hold BBH as of Q3 2026.

  • CIBC Bancorp USA held 4,958 shares of VanEck Biotech ETF worth $1.21M as of Q3 2026.
  • CIBC Bancorp USA left its VanEck Biotech ETF share count unchanged in Q3 2026.
  • VanEck Biotech ETF made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1067 holding.
  • CIBC Bancorp USA first reported a position in VanEck Biotech ETF in Q1 2026 and has held it in 3 quarters since.
  • 103 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.